Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Editorial

  • Editorial
    Dihydropyrimidine Dehydrogenase Activity: Prognostic Partner of 5-Fluorouracil?
    Carmen J. Allegra
    Clin Cancer Res August 1 1999 5 (8) 1947-1949;

Review

  • Review
    Molecular Detection of Micrometastases and Circulating Tumor Cells in Solid Tumors
    Ronald A. Ghossein, Satyajit Bhattacharya and Juan Rosai
    Clin Cancer Res August 1 1999 5 (8) 1950-1960;

Advances in Brief

  • Advances in Brief
    Detection of Tumor Messenger RNA in the Serum of Patients with Malignant Melanoma
    Michael S. Kopreski, Floyd A. Benko, Larry W. Kwak and Christopher D. Gocke
    Clin Cancer Res August 1 1999 5 (8) 1961-1965;

  • Advances in Brief
    Tissue Microarrays for Gene Amplification Surveys in Many Different Tumor Types
    Peter Schraml, Juha Kononen, Lukas Bubendorf, Holger Moch, Heidi Bissig, Antonio Nocito, Michael J. Mihatsch, Olli-P. Kallioniemi and Guido Sauter
    Clin Cancer Res August 1 1999 5 (8) 1966-1975;

  • Advances in Brief
    Suicide Prodrugs Activated by Thymidylate Synthase: Rationale for Treatment and Noninvasive Imaging of Tumors with Deoxyuridine Analogues
    Jerry M. Collins, Raymond W. Klecker and Aspandiar G. Katki
    Clin Cancer Res August 1 1999 5 (8) 1976-1981;

  • Advances in Brief
    Inhibition of Matrix Metalloproteinase-2 Expression and Bladder Carcinoma Metastasis by Halofuginone
    Michael Elkin, Reuven Reich, Arnon Nagler, Elena Aingorn, Mark Pines, Nathan de-Groot, Avraham Hochberg and Israel Vlodavsky
    Clin Cancer Res August 1 1999 5 (8) 1982-1988;

Clinical Trials

  • Clinical Trials
    A Phase I and Pharmacokinetic Study of TNP-470 Administered Weekly to Patients with Advanced Cancer
    Pankaj Bhargava, John L. Marshall, Naiyer Rizvi, William Dahut, Joseph Yoe, Manuela Figuera, Kim Phipps, Voon S. Ong, Allen Kato and Michael J. Hawkins
    Clin Cancer Res August 1 1999 5 (8) 1989-1995;

  • Clinical Trials
    Thymidylate Synthase Protein Expression in Advanced Colon Cancer: Correlation with the Site of Metastasis and the Clinical Response to Leucovorin-modulated Bolus 5-Fluorouracil
    Stefano Cascinu, Carlo Aschele, Sandro Barni, Domizia Debernardis, Chiara Baldo, Gianni Tunesi, Vincenzo Catalano, Maria Pia Staccioli, Ambrogio Brenna, Pietro Muretto and Giuseppina Catalano
    Clin Cancer Res August 1 1999 5 (8) 1996-1999;

  • Clinical Trials
    Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug
    Koichi Hirata, Noboru Horikoshi, Keisuke Aiba, Minoru Okazaki, Ryuichi Denno, Kazuaki Sasaki, Yasuyuki Nakano, Hikaru Ishizuka, Yasuhide Yamada, Shinji Uno, Tetsuo Taguchi and Tetsuhiko Shirasaka
    Clin Cancer Res August 1 1999 5 (8) 2000-2005;

  • Clinical Trials
    Life-Threatening Toxicity in a Dihydropyrimidine Dehydrogenase-deficient Patient after Treatment with Topical 5-Fluorouracil
    Martin R. Johnson, Alexander Hageboutros, Kangsheng Wang, Lisa High, Jeffrey B. Smith and Robert B. Diasio
    Clin Cancer Res August 1 1999 5 (8) 2006-2011;

  • Clinical Trials
    Drug-Administration Sequence Does Not Change Pharmacodynamics and Kinetics of Irinotecan and Cisplatin
    Maja J. A. de Jonge, Jaap Verweij, André S. T. Planting, Maria E. L. van der Burg, Gerrit Stoter, Maureen M. de Boer-Dennert, Peter de Bruijn, Eric Brouwer, Laurent Vernillet and Alex Sparreboom
    Clin Cancer Res August 1 1999 5 (8) 2012-2017;

Molecular Oncology, Markers, Clinical Correlates

  • Molecular Oncology, Markers, Clinical Correlates
    Overexpression of Cyclooxygenase-2 in Carcinoma of the Pancreas
    Jiro Okami, Hirofumi Yamamoto, Yoshiyuki Fujiwara, Masaki Tsujie, Motoi Kondo, Shingo Noura, Satoshi Oshima, Hiroaki Nagano, Keizo Dono, Koji Umeshita, Osamu Ishikawa, Masato Sakon, Nariaki Matsuura, Shoji Nakamori and Morito Monden
    Clin Cancer Res August 1 1999 5 (8) 2018-2024;

  • Molecular Oncology, Markers, Clinical Correlates
    Loss of Heterozygosity in Epithelial Cells Obtained by Bronchial Brushing: Clinical Utility in Lung Cancer
    Charles A. Powell, Scott Klares, George O’Connor and Jerome S. Brody
    Clin Cancer Res August 1 1999 5 (8) 2025-2034;

  • Molecular Oncology, Markers, Clinical Correlates
    Prognostic Value of Ornithine Decarboxylase and Polyamines in Human Breast Cancer: Correlation with Clinicopathologic Parameters
    Francisco Cañizares, Juan Salinas, Manuel de las Heras, Julian Diaz, Isabel Tovar, Pedro Martinez and Rafael Peñafiel
    Clin Cancer Res August 1 1999 5 (8) 2035-2041;

  • Molecular Oncology, Markers, Clinical Correlates
    Association between Molecular Detection of GAGE and Survival in Patients with Malignant Melanoma: A Retrospective Cohort Study
    Irene Y. Cheung, Nai-Kong V. Cheung, Ronald A. Ghossein, Jaya M. Satagopan, Satyajit Bhattacharya and Daniel G. Coit
    Clin Cancer Res August 1 1999 5 (8) 2042-2047;

  • Molecular Oncology, Markers, Clinical Correlates
    Expression of DNA Topoisomerase IIα and Topoisomerase IIβ Genes Predicts Survival and Response to Chemotherapy in Patients with Small Cell Lung Cancer
    Anne-Marie C. Dingemans, M. Adhiambo Witlox, Roland A. L. M. Stallaert, Paul van der Valk, Pieter E. Postmus and Giuseppe Giaccone
    Clin Cancer Res August 1 1999 5 (8) 2048-2058;

  • Molecular Oncology, Markers, Clinical Correlates
    O6-Alkylguanine-DNA Alkyltransferase in Cutaneous T-Cell Lymphoma: Implications for Treatment with Alkylating Agents
    M. Eileen Dolan, Bradford L. McRae, Elizabeth Ferries-Rowe, Michael Belanich, Gijs A. van Seventer, Joan Guitart, David Pezen, Timothy M. Kuzel and Daniel B. Yarosh
    Clin Cancer Res August 1 1999 5 (8) 2059-2064;

  • Molecular Oncology, Markers, Clinical Correlates
    Prognostic Significance of Perirectal Lymph Node Micrometastases in Dukes’ B Rectal Carcinoma: An Immunohistochemical Study by CAM5.2
    Naohide Isaka, Mutsumi Nozue, Mikio Doy and Katashi Fukao
    Clin Cancer Res August 1 1999 5 (8) 2065-2068;

  • Molecular Oncology, Markers, Clinical Correlates
    Overexpression of Cyclin D1 Messenger RNA Predicts for Poor Prognosis in Estrogen Receptor-positive Breast Cancer
    Frances S. Kenny, Rina Hui, Elizabeth A. Musgrove, Julia M.W. Gee, Roger W. Blamey, Robert I. Nicholson, Robert L. Sutherland and John F. R. Robertson
    Clin Cancer Res August 1 1999 5 (8) 2069-2076;

  • Molecular Oncology, Markers, Clinical Correlates
    Telomerase Activity as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer
    Antonio Marchetti, Gloria Bertacca, Fiamma Buttitta, Antonio Chella, Gianluca Quattrocolo, Carlo Alberto Angeletti and Generoso Bevilacqua
    Clin Cancer Res August 1 1999 5 (8) 2077-2081;

  • Molecular Oncology, Markers, Clinical Correlates
    Inactivation of the p53 Pathway in Prostate Cancer: Impact on Tumor Progression
    Iman Osman, Marija Drobnjak, Melissa Fazzari, Joseph Ferrara, Howard I. Scher and Carlos Cordon-Cardo
    Clin Cancer Res August 1 1999 5 (8) 2082-2088;

  • Molecular Oncology, Markers, Clinical Correlates
    Wild-Type p53 Epitope Naturally Processed and Presented by an HLA-B Haplotype on Human Breast Carcinoma Cells
    Kyriakos P. Papadopoulos, Charles S. Hesdorffer, Nicole Suciu-Foca, Hanina Hibshoosh and Paul E. Harris
    Clin Cancer Res August 1 1999 5 (8) 2089-2093;

  • Molecular Oncology, Markers, Clinical Correlates
    Expression of Plasminogen Activator Inhibitors 1 and 2 in Lung Cancer and Their Role in Tumor Progression
    Catherine Robert, Isabelle Bolon, Sylvie Gazzeri, Sylvie Veyrenc, Christian Brambilla and Elisabeth Brambilla
    Clin Cancer Res August 1 1999 5 (8) 2094-2102;

  • Molecular Oncology, Markers, Clinical Correlates
    The Human Orphan Receptor PXR Messenger RNA Is Expressed in Both Normal and Neoplastic Breast Tissue
    Helmut Dotzlaw, Etienne Leygue, Peter Watson and Leigh C. Murphy
    Clin Cancer Res August 1 1999 5 (8) 2103-2107;

  • Molecular Oncology, Markers, Clinical Correlates
    Sequences Homologous to the Mouse Mammary Tumor Virus env Gene in Human Breast Carcinoma Correlate with Overexpression of Laminin Receptor
    Beatriz G-T. Pogo, Stella M. Melana, James F. Holland, John F. Mandeli, Silvana Pilotti, Patrizia Casalini and Sylvie Ménard
    Clin Cancer Res August 1 1999 5 (8) 2108-2111;

  • Molecular Oncology, Markers, Clinical Correlates
    Expression of Dominant-Negative Ikaros Isoforms in T-Cell Acute Lymphoblastic Leukemia
    Lei Sun, Mya-Lisa Crotty, Martha Sensel, Harland Sather, Christopher Navara, James Nachman, Peter G. Steinherz, Paul S. Gaynon, Nita Seibel, Chen Mao, Alexei Vassilev, Gregory H. Reaman and Fatih M. Uckun
    Clin Cancer Res August 1 1999 5 (8) 2112-2120;

  • Molecular Oncology, Markers, Clinical Correlates
    Minichromosome Maintenance Proteins as Biological Markers of Dysplasia and Malignancy
    Alex Freeman, Lesley S. Morris, Anthony D. Mills, Kai Stoeber, Ronald A. Laskey, Gareth H. Williams and Nicholas Coleman
    Clin Cancer Res August 1 1999 5 (8) 2121-2132;

  • Molecular Oncology, Markers, Clinical Correlates
    Analysis of Cyclin D1 (CCND1) Allelic Imbalance and Overexpression in Sporadic Human Pituitary Tumors
    Nigel A. Hibberts, David J. Simpson, John E. Bicknell, John C. Broome, Paul R. Hoban, Richard N. Clayton and William E. Farrell
    Clin Cancer Res August 1 1999 5 (8) 2133-2139;

Experimental Therapeutics, Preclinical Pharmacology

  • Experimental Therapeutics, Preclinical Pharmacology
    Adenovirus-mediated p53 Gene Transduction Inhibits Telomerase Activity Independent of Its Effects on Cell Cycle Arrest and Apoptosis in Human Pancreatic Cancer Cells
    Masahiro Kusumoto, Takahiro Ogawa, Kazuhiro Mizumoto, Hikaru Ueno, Hideaki Niiyama, Norihiro Sato, Masafumi Nakamura and Masao Tanaka
    Clin Cancer Res August 1 1999 5 (8) 2140-2147;

  • Experimental Therapeutics, Preclinical Pharmacology
    Oral Administration of the Immunomodulator JBT-3002 Induces Endogenous Interleukin 15 in Intestinal Macrophages for Protection against Irinotecan-mediated Destruction of Intestinal Epithelium
    Hisashi Shinohara, Jerald J. Killion, Corazon D. Bucana, Seiji Yano and Isaiah J. Fidler
    Clin Cancer Res August 1 1999 5 (8) 2148-2156;

  • Experimental Therapeutics, Preclinical Pharmacology
    Efficacy of Recombinant Methioninase in Combination with Cisplatin on Human Colon Tumors in Nude Mice
    Yuying Tan, Xinghua Sun, Mingxu Xu, Xuezhong Tan, Aaron Sasson, Babak Rashidi, Qinghong Han, Xiuying Tan, Xiaoen Wang, Zili An, Fan-xian Sun and Robert M. Hoffman
    Clin Cancer Res August 1 1999 5 (8) 2157-2163;

  • Experimental Therapeutics, Preclinical Pharmacology
    Decreased Src Tyrosine Kinase Activity Inhibits Malignant Human Ovarian Cancer Tumor Growth in a Nude Mouse Model
    Jon R. Wiener, Kayo Nakano, Russell P. Kruzelock, Corazon D. Bucana, Robert C. Bast Jr. and Gary E. Gallick
    Clin Cancer Res August 1 1999 5 (8) 2164-2170;

  • Experimental Therapeutics, Preclinical Pharmacology
    Androgen and Epidermal Growth Factor Down-Regulate Cyclin-dependent Kinase Inhibitor p27Kip1 and Costimulate Proliferation of MDA PCa 2a and MDA PCa 2b Prostate Cancer Cells
    Dingwei Ye, John Mendelsohn and Zhen Fan
    Clin Cancer Res August 1 1999 5 (8) 2171-2177;

  • Experimental Therapeutics, Preclinical Pharmacology
    Chlorambucil Induction of HsRad51 in B-Cell Chronic Lymphocytic Leukemia
    Garyfallia Christodoulopoulos, Areti Malapetsa, Hymen Schipper, Efim Golub, Charles Radding and Lawrence C. Panasci
    Clin Cancer Res August 1 1999 5 (8) 2178-2184;

  • Experimental Therapeutics, Preclinical Pharmacology
    UFT and Its Metabolites Inhibit the Angiogenesis Induced by Murine Renal Cell Carcinoma, as Determined by a Dorsal Air Sac Assay in Mice
    Kazuhiko Yonekura, Yuji Basaki, Lumi Chikahisa, Soko Okabe, Akihiro Hashimoto, Kazutaka Miyadera, Konstanty Wierzba and Yuji Yamada
    Clin Cancer Res August 1 1999 5 (8) 2185-2191;

  • Experimental Therapeutics, Preclinical Pharmacology
    Metabolic Activation of Dacarbazine by Human Cytochromes P450: The Role of CYP1A1, CYP1A2, and CYP2E1
    Joel M. Reid, Mary J. Kuffel, Jennifer K. Miller, Robert Rios and Matthew M. Ames
    Clin Cancer Res August 1 1999 5 (8) 2192-2197;

  • Experimental Therapeutics, Preclinical Pharmacology
    Anticancer Drug Sensitivity and Expression of Multidrug Resistance Markers in Early Passage Human Sarcomas
    Jens Hoffmann, Peter Schmidt-Peter, Wolfgang Hänsch, Helga Naundorf, Andreas Bunge, Michael Becker and Iduna Fichtner
    Clin Cancer Res August 1 1999 5 (8) 2198-2204;

  • Experimental Therapeutics, Preclinical Pharmacology
    The Trk Tyrosine Kinase Inhibitor CEP-701 (KT-5555) Exhibits Significant Antitumor Efficacy in Preclinical Xenograft Modelsof Human Pancreatic Ductal Adenocarcinoma
    Sheila J. Miknyoczki, Hong Chang, Andres Klein-Szanto, Craig A. Dionne and Bruce A. Ruggeri
    Clin Cancer Res August 1 1999 5 (8) 2205-2212;

  • Experimental Therapeutics, Preclinical Pharmacology
    Paclitaxel and Radiotherapy: Sequence-dependent Efficacy—A Preclinical Model
    Alessandra Niero, Ermanno Emiliani, Giuseppe Monti, Flavio Pironi, Livia Turci, Anna Maria Valenti and Maurizio Marangolo
    Clin Cancer Res August 1 1999 5 (8) 2213-2222;

  • Experimental Therapeutics, Preclinical Pharmacology
    Lovastatin Augments Apoptosis Induced by Chemotherapeutic Agents in Colon Cancer Cells
    Banke Agarwal, Sanjay Bhendwal, Balasz Halmos, Steven F. Moss, William G. Ramey and Peter R. Holt
    Clin Cancer Res August 1 1999 5 (8) 2223-2229;

  • Experimental Therapeutics, Preclinical Pharmacology
    Fenretinide Activates Caspases and Induces Apoptosis in Gliomas
    Vinaykumar K. Puduvalli, Yoshiki Saito, Ruishu Xu, Gregory P. Kouraklis, Victor A. Levin and Athanassios P. Kyritsis
    Clin Cancer Res August 1 1999 5 (8) 2230-2235;

  • Experimental Therapeutics, Preclinical Pharmacology
    Identification of a MAGE-2-encoded Human Leukocyte Antigen-A24-binding Synthetic Peptide That Induces Specific Antitumor Cytotoxic T Lymphocytes
    Kouichirou Tahara, Kazutoh Takesako, Alessandro Sette, Esteban Celis, Seigo Kitano and Tsuyoshi Akiyoshi
    Clin Cancer Res August 1 1999 5 (8) 2236-2241;

  • Experimental Therapeutics, Preclinical Pharmacology
    Adenovirus-mediated E2F-1 Gene Transfer Inhibits MDM2 Expression and Efficiently Induces Apoptosis in MDM2-overexpressing Tumor Cells
    Hai Liang Yang, Yan Bin Dong, Mary Jane Elliott, Ta Jen Liu, Cesar Atienza Jr., Ariel Stilwell and Kelly M. McMasters
    Clin Cancer Res August 1 1999 5 (8) 2242-2250;

Cancer Biology, Immunology, Cytokines

  • Cancer Biology, Immunology, Cytokines
    A Role for Phospholipase C-γ-mediated Signaling in Tumor Cell Invasion
    Jareer Kassis, Jason Moellinger, Han Lo, Norman M. Greenberg, Hyung-Gyoon Kim and Alan Wells
    Clin Cancer Res August 1 1999 5 (8) 2251-2260;

  • Cancer Biology, Immunology, Cytokines
    Surface Membrane-expressed CD40 Is Present on Tumor Cells from Squamous Cell Cancer of the Head and Neck in Vitro and in Vivo and Regulates Cell Growth in Tumor Cell Lines
    Marshall R. Posner, Lisa A. Cavacini, Melissa P. Upton, Karl C. Tillman, Eric R. Gornstein and Charles M. Norris Jr.
    Clin Cancer Res August 1 1999 5 (8) 2261-2270;

  • Cancer Biology, Immunology, Cytokines
    Osteopontin: Possible Role in Prostate Cancer Progression
    George N. Thalmann, R. A. Sikes, R. E. Devoll, J. A. Kiefer, R. Markwalder, I. Klima, C. M. Farach-Carson, U. E. Studer and L. W. K. Chung
    Clin Cancer Res August 1 1999 5 (8) 2271-2277;

Back to top
PreviousNext
August 1999
Volume 5, Issue 8
  • Table of Contents

Sign up for alerts

Jump to

  • Editorial
  • Review
  • Advances in Brief
  • Clinical Trials
  • Molecular Oncology, Markers, Clinical Correlates
  • Experimental Therapeutics, Preclinical Pharmacology
  • Cancer Biology, Immunology, Cytokines
Advertisement
  • Most Cited
  • Most Read
Loading
  • scRNA-seq Analysis of Gastric Cancer TME
  • Toxicity Management Affects Checkpoint Inhibitor Efficacy
  • PDAC and GATA6 Expression
  • Rucaparib in mCRPC with a Non-BRCA DDR Gene Alteration
  • AR Gene Rearrangements in Prostate Cancer
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement